Compare · HIMS vs LFMD
HIMS vs LFMD
Side-by-side comparison of Hims & Hers Health Inc. (HIMS) and LifeMD Inc. (LFMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIMS and LFMD operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $7.60B, about 37.9x LFMD ($200.7M).
- Over the past year, HIMS is down 31.0% and LFMD is down 60.2% - HIMS leads by 29.2 points.
- HIMS has hit the wire 5 times in the past 4 weeks while LFMD has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 11 for LFMD).
- Company
- Hims & Hers Health Inc.
- LifeMD Inc.
- Price
- $32.86-2.41%
- $4.14-8.20%
- Market cap
- $7.60B
- $200.7M
- 1M return
- +4.42%
- -14.46%
- 1Y return
- -30.98%
- -60.23%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- News (4w)
- 5
- 0
- Recent ratings
- 25
- 11
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
LifeMD Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
Latest HIMS
- Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
- Hims & Hers Health Inc. filed SEC Form 8-K: Leadership Update
- Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $261,351 worth of shares (7,163 units at $36.49) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chief Medical Officer Carroll Patrick Harrison sold $830,410 worth of shares (23,726 units at $35.00), decreasing direct ownership by 12% to 181,861 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi exercised 6,376 shares at a strike of $5.01 and sold $619,217 worth of shares (18,197 units at $34.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 284,321 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax
- Chief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)
- Chief Operating Officer Chi Michael covered exercise/tax liability with 47,699 shares, sold $441,850 worth of shares (14,027 units at $31.50) as part of a pre-agreed trading plan and converted options into 86,264 shares, increasing direct ownership by 6% to 432,124 units (SEC Form 4) (withholding obligation)
Latest LFMD
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
- LifeMD Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
- Chief Technology Officer Sripad Umesh was granted 75,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Sripad Umesh
- LifeMD Appoints Umesh Sripad as Chief Technology Officer
- LifeMD to Participate in Upcoming Investor Conferences
- Chief Financial Officer Kavthekar Atul was granted 337,500 shares (SEC Form 4)
- SEC Form 10-Q filed by LifeMD Inc.
- LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits